bpc 157 cycle length protocol BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or Best Way to Take BPC
Description
Subcutaneous injections deliver nutrients into the fatty tissue under the skin

10.3390/toxins10040146 266 ShinS.-H.YeM.-K.ChoiS.-Y.ParkK.-K

2017;8:CD006612
There is a very short study on Methionine restriction involving a small sample size of human patients

Mixed effects modelling of excess mortality and COVID-19 lockdowns in Thailand

Is BPC-157 a peptide or a protein
